The Efficacy of Phenol-Glucose-Glycerin Mixtures as a Prolotherapy Proliferative Substance on Fibroblast Tissue Culture

The number of Americans living with osteoarthritis today is estimated to be around 63 million. As the U.S. population ages, that number is projected to be as high as 78 million by 2040. Prolotherapy has served as a potential therapeutic that is both an alternative to joint replacement and more financially feasible compared to bio-injectables. However, significant gaps remain in our understanding of its molecular mechanisms and safety. While dextrose has become an increasingly popular prolotherapy substance, a cocktail composed of Phenol-glucose-glycerin (P2G) has also been historically used.
Source: The Journal of Pain - Category: Materials Science Authors: Source Type: research